Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01480050
What this trial is testing

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Early research (Phase 1)Study completedNCT04156750
What this trial is testing

LY3556050 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 34
Testing effectiveness (Phase 2)Study completedNCT00943540
What this trial is testing

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIV Infections
Radboud University Medical Center 20
Early research (Phase 1)Study completedNCT02156388
What this trial is testing

Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors

Who this might be right for
Chemotherapy-induced NeutropeniaMetastatic Tumors
Jiangsu T-Mab Biopharma Co.,Ltd 31
Early research (Phase 1)Study completedNCT01820442
What this trial is testing

Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients

Who this might be right for
Opioid DependenceBuprenorphine Withdrawal Syndrome
USWM, LLC (dba US WorldMeds) 30
Early research (Phase 1)Ended earlyNCT00558727
What this trial is testing

Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Advanced Solid TumorsNon-Hodgkin's Lymphoma
Spectrum Pharmaceuticals, Inc 12
Early research (Phase 1)Study completedNCT04874142
What this trial is testing

Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

Who this might be right for
Dyslipidemias
Yooyoung Pharmaceutical Co., Ltd. 48
Early research (Phase 1)Study completedNCT00938288
What this trial is testing

KW-3357 in Congenital Antithrombin Deficiency

Who this might be right for
Congenital Antithrombin Deficiency
Kyowa Kirin Co., Ltd. 16
Early research (Phase 1)Study completedNCT07251127
What this trial is testing

Study of Metronidazole Delayed-Release Capsules in Comparison With Immediate-Release Tablets (Flagyl) for Safety and Pharmacokinetics

Who this might be right for
Clostridium Difficile Infection (CDI)
Gateway Pharmaceutical LLC 18
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Early research (Phase 1)Study completedNCT03510104
What this trial is testing

Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors

Who this might be right for
Advanced CancerMetastatic CancerNeoplasms+3 more
Meryx, Inc. 42
Early research (Phase 1)Ended earlyNCT04940949
What this trial is testing

Evaluate Lu AF90103 in Healthy Men

Who this might be right for
Healthy
H. Lundbeck A/S 15
Early research (Phase 1)Study completedNCT01356043
What this trial is testing

CKD-828 Drug Interaction Study (S-amlodipine)

Who this might be right for
Healthy Male Volunteers
Chong Kun Dang Pharmaceutical 24
Early research (Phase 1)Study completedNCT05915247
What this trial is testing

Single Ascending Doses of HER-096 in Healthy Subjects

Who this might be right for
Parkinson Disease
Herantis Pharma Plc. 60
Large-scale testing (Phase 3)Study completedNCT03315455
What this trial is testing

Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants

Who this might be right for
Hemophilia A
Hoffmann-La Roche 85
Early research (Phase 1)Looking for participantsNCT07237425
What this trial is testing

Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma

Who this might be right for
LipomaSubmental Fullness
Glonova Pharma Co., Ltd 56
Early research (Phase 1)Study completedNCT03595189
What this trial is testing

Safety, Tolerability and Pharmacokinetic Profile of an Infusion of Cilastatin in Healthy Volunteers.

Who this might be right for
Dose Finding Study
Spherium Biomed 23
Early research (Phase 1)Study completedNCT02354950
What this trial is testing

Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers

Who this might be right for
HIV Infections
ViiV Healthcare 16
Early research (Phase 1)Study completedNCT01304303
What this trial is testing

Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination

Who this might be right for
Solid Tumor in Advanced Stage
Sun Pharma Advanced Research Company Limited 57
Early research (Phase 1)Study completedNCT03451162
What this trial is testing

Safety, Tolerability, and Pharmacokinetic (PK) Study of DHES0815A in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Genentech, Inc. 14
Next Page